TrialMedical oncology (Northwood, London, England)2024

Possible protective effect of rosuvastatin in chemotherapy-induced cardiotoxicity in HER2 positive breast cancer patients: a randomized controlled trial.

Khlood M Kettana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.